NEW YORK (GenomeWeb) — Diagnostic tools developer Protagen AG announced this week that it will join the RA-MAP Consortium, a collaboration of 10 universities and 10 companies working together to identify the key predictors of clinical response and remission in rheumatoid arthritis (RA) patients, and to identify those at high risk of developing the disease. Protagen will contribute its proprietary SeroTag diagnostic platform to search for RA biomarkers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.